mild cognitive impairment Cytox Gets CE Mark for Alzheimer's Disease Genetic Risk Test The polygenic risk test analyzes an individual's genes for more than 100,000 SNPs associated with the risk of developing Alzheimer's disease. DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome. Alzheimer's Disease Neuroimaging Initiative Enters Third Phase The initiative was launched to conduct a large-scale study of cognitive impairment and Alzheimer's disease to advance the discovery of biomarkers of the conditions. Affymetrix, Cytox Partner on Alzheimer's Disease Risk Dx The partners will collaborate on the development of a custom SNP panel to predict an individual's Alzheimer's disease or MCI risk. Estonian Population Profiling Reveals Recurrent, Rare CNVs Linked to Intellectual Ability More than 10 percent of individuals in an unselected population carried recurrent syndrome-associated CNVs or rare autosomal CNVs with potential ties to cognitive ability. Mar 16, 2015 Diamir Receives $1.5M NIH Grant to Advance microRNA Dx for Alzheimer's Nov 21, 2014 New Blood-based Alzheimer's Biomarker Panel Uses Exosomal miRNA Premium Jul 14, 2014 C2N, WUSTL Expand Partnership to Commercialize Alzheimer's Test Nov 4, 2013 Genomind, Emory Partner to Commercialize Alzheimer's Test Jun 6, 2013 DiaGenic Adopts Life Tech QuantStudio Dx for Alzheimer's Test Development Premium Mar 29, 2012 DiaGenic-GE Pact Aims for MDx Test to ID Alzheimer's Risk Patients for Follow-up PET Imaging Premium Mar 22, 2012 NINR Seeks Biomarker, Imaging Studies of Mild Cognitive Impairment Nov 4, 2011 Myriad Moving Eight Protein-Based Tests to Market; Priorities Include AD, Kidney Damage, Colon Cancer Premium Dec 10, 2010 Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's Premium Oct 7, 2010 Norwegian MDx Firm DiaGenic Raises $12.1M While Refocusing Business on Neuro Market Premium Sep 17, 2010 TARC Team Uses RBM's DiscoveryMAP Platform to Develop Alzheimer's Protein-Biomarker Test Premium Jun 11, 2010 ADNI Researchers and Industry Partners Developing Proteomic Profiles to Track Alzheimer's Disease Premium Breaking News Liver Cancers Detected With Parallel Mutation, Methylation Liquid Biopsy Approach In Brief This Week: Biocept, Thermo Fisher, Biodesix, More Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test Lucira Health Molecular COVID/Flu Test Gets FDA Emergency Use Authorization Biocare Medical Acquires Empire Genomics The Scan UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways. Survey Sees Genetic Literacy on the Rise, Though Further Education Needed Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds. Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers. FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.